After two and a half years, the Medicare demonstration project designed to identify ways of lowering spending on cancer care while supporting quality is exposing the fact that high and rising prescription drug costs have a disproportionate impact on overall expenses.
That will increase the scrutiny of drug spending under the program going forward. It seems unlikely that providers can or...







